IL97140A - Tricyclic-cyclic amines and cholinesterase inhibitors containing them - Google Patents

Tricyclic-cyclic amines and cholinesterase inhibitors containing them

Info

Publication number
IL97140A
IL97140A IL9714091A IL9714091A IL97140A IL 97140 A IL97140 A IL 97140A IL 9714091 A IL9714091 A IL 9714091A IL 9714091 A IL9714091 A IL 9714091A IL 97140 A IL97140 A IL 97140A
Authority
IL
Israel
Prior art keywords
phenylmethyl
indol
methyl
piperidinyl
dihydro
Prior art date
Application number
IL9714091A
Other languages
English (en)
Hebrew (he)
Other versions
IL97140A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL97140A0 publication Critical patent/IL97140A0/xx
Publication of IL97140A publication Critical patent/IL97140A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL9714091A 1990-02-08 1991-02-03 Tricyclic-cyclic amines and cholinesterase inhibitors containing them IL97140A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47692890A 1990-02-08 1990-02-08

Publications (2)

Publication Number Publication Date
IL97140A0 IL97140A0 (en) 1992-05-25
IL97140A true IL97140A (en) 1995-07-31

Family

ID=23893824

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9714091A IL97140A (en) 1990-02-08 1991-02-03 Tricyclic-cyclic amines and cholinesterase inhibitors containing them

Country Status (21)

Country Link
EP (1) EP0441517A3 (sh)
JP (1) JPH07119214B2 (sh)
KR (1) KR950013562B1 (sh)
CN (1) CN1054600A (sh)
AU (1) AU631723B2 (sh)
BR (1) BR9100519A (sh)
CA (1) CA2035805C (sh)
CS (1) CS29991A2 (sh)
DE (1) DE9101348U1 (sh)
EG (1) EG19644A (sh)
FI (1) FI910592A (sh)
HU (1) HUT70051A (sh)
IE (1) IE910402A1 (sh)
IL (1) IL97140A (sh)
NO (1) NO177534C (sh)
NZ (1) NZ237040A (sh)
PL (2) PL166757B1 (sh)
PT (1) PT96681A (sh)
TW (1) TW197442B (sh)
YU (1) YU21391A (sh)
ZA (1) ZA91916B (sh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2807577B2 (ja) * 1990-06-15 1998-10-08 エーザイ株式会社 環状アミド誘導体
EP0475908A1 (de) * 1990-09-14 1992-03-18 Ciba-Geigy Ag Chromogene Lactamverbindungen und ihre Herstellung und Verwendung
TW263504B (sh) * 1991-10-03 1995-11-21 Pfizer
TW248556B (sh) * 1993-01-18 1995-06-01 Takeda Pharm Industry Co
US5620973A (en) * 1993-11-30 1997-04-15 Takeda Chemical Industries, Ltd. Tetracyclic condensed heterocyclic compounds and their use
EP1604653A1 (en) 1998-09-30 2005-12-14 Takeda Pharmaceutical Company Limited Acetylcholinesterase inhibitors for improving excretory potency of urinary bladder
EP1558614B1 (en) * 2002-10-30 2010-09-01 Merck Frosst Canada Ltd. Pyridopyrrolizine and pyridoindolizine derivatives
US7662831B2 (en) 2006-07-27 2010-02-16 Wyeth Llc Tetracyclic indoles as potassium channel modulators
US7601856B2 (en) 2006-07-27 2009-10-13 Wyeth Benzofurans as potassium ion channel modulators
WO2012038966A1 (en) 2010-09-22 2012-03-29 Tyche Industries Ltd. Process for the preparation of donepezil intermediate
AR112788A1 (es) * 2017-09-07 2019-12-11 Eisai R&D Man Co Ltd Compuesto pentacíclico
EP3936190A4 (en) 2019-03-05 2022-11-16 Eisai R&D Management Co., Ltd. PENTACYCLIC HETEROCYCLIC COMPOUND
KR20210135223A (ko) 2019-03-05 2021-11-12 에자이 알앤드디 매니지먼트 가부시키가이샤 펜타시클릭 화합물의 염 및 이의 결정

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910947A (en) * 1969-07-24 1975-10-07 Sandoz Ag Preparation of imidazo{8 2,1-a{9 isoindoles
IT1199076B (it) * 1984-03-01 1988-12-30 Consiglio Nazionale Ricerche Derivati della fisostigmina con proprieta'di inibizione della aceticolinesterasi e relativo procedimento di produzione
US4563469A (en) * 1984-07-20 1986-01-07 Warner-Lambert Company Derivatives of N-[2-(tetrahydro-3,5-dioxo-1H-pyrrolizin-7a(5H)-yl)ethyl]amine as cognition activators
EP0187619A3 (de) * 1985-01-03 1987-08-26 Ciba-Geigy Ag 1,3-disubstituierte Tetrahydropyridine
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
US4778812A (en) * 1987-06-12 1988-10-18 American Home Products Corporation 2,3-dihydro-9-methyl-1H-pyrrolo[1,2-a]indol-1-amines and derivatives thereof
EP0351283A1 (fr) * 1988-07-12 1990-01-17 Synthelabo Dérivés de [(pipéridinyl-4) méthyl]-2 dihydro-2,3 1H-isoindole et tétrahydro-2,3,4,5 1H-benzazépines, leur préparation et leur application en thérapeutique

Also Published As

Publication number Publication date
PL166757B1 (pl) 1995-06-30
TW197442B (sh) 1993-01-01
PL167078B1 (pl) 1995-07-31
NZ237040A (en) 1993-10-26
PL288977A1 (en) 1992-01-13
JPH07119214B2 (ja) 1995-12-20
NO910473L (no) 1991-08-09
JPH04234845A (ja) 1992-08-24
PT96681A (pt) 1991-10-31
EG19644A (en) 1995-08-30
KR950013562B1 (ko) 1995-11-09
ZA91916B (en) 1992-09-30
EP0441517A3 (en) 1992-08-19
YU21391A (sh) 1994-01-20
CA2035805C (en) 1995-06-27
AU7087991A (en) 1991-08-29
CN1054600A (zh) 1991-09-18
DE9101348U1 (de) 1991-06-06
FI910592A0 (fi) 1991-02-07
NO177534C (no) 1995-10-04
BR9100519A (pt) 1991-10-29
FI910592A (fi) 1991-08-09
EP0441517A2 (en) 1991-08-14
IE910402A1 (en) 1991-08-14
NO177534B (no) 1995-06-26
IL97140A0 (en) 1992-05-25
KR910015580A (ko) 1991-09-30
NO910473D0 (no) 1991-02-07
AU631723B2 (en) 1992-12-03
HU910406D0 (en) 1991-08-28
HUT70051A (en) 1995-09-28
CS29991A2 (en) 1991-09-15

Similar Documents

Publication Publication Date Title
US5100902A (en) 1,2-benzisoxazole compounds
US6849619B2 (en) Substituted pyridoindoles as serotonin agonists and antagonists
EP1192165B1 (en) Substituted heterocycle fused gamma-carbolines
JP4231290B2 (ja) セロトニンの作動薬および拮抗薬としての置換されたピリドインドール
CA2432181C (en) Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists
US6303633B1 (en) Heteroaryl amines as novel acetylcholinesterase inhibitors
Moltzen et al. . sigma. Ligands with Subnanomolar Affinity and Preference for the. sigma. 2 Binding Site. 2. Spiro-Joined Benzofuran, Isobenzofuran, and Benzopyran Piperidines
CA2035805C (en) Tricyclic-cyclic amines as novel cholinesterase inhibitors
HU205354B (en) Process for producing new tricyclic benzimidazoles and pharmaceutical compositions comprising same
AU2006228426A1 (en) Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia
NZ250580A (en) 3-(hetero)aryloxymorphinan derivatives and their use in the manufacture of medicaments
AU2002300094B2 (en) New octahydro-2H-pyrido[1,2-alpha]pyrazine compounds, a process for their preparation and pharmaceutical compositions containing them
CA1177830A (en) Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US5965574A (en) Heteroaryl amines as novel acetylcholinesterase inhibitors
IL95323A (en) History of Pipridine 4,4- Transformed, preparation and pharmaceutical preparations containing them
US5428043A (en) Tricyclic-cyclic amines as novel cholinesterase inhibitors
US4379933A (en) Process for preparing spiro[indoline-3,4'-piperidine]s
KR20090096748A (ko) 아미노피롤로[1,2-a]인돌 및 아미노피리다지노[1,6-a]인돌 유도체, 및 이의 제조 방법 및 이를 포함하는 약제 조성물
US4345081A (en) Spiro[indoline-3,4'-piperidine]s
KR20010072262A (ko) 삼환식 카르복스아미드
US4408050A (en) Spiro(indoline-3,4'-piperidine) and related compounds
US4477667A (en) Spiro[indoline-3,4'-piperidine]s and related compounds
US4379932A (en) Process for preparing spiro[indoline-3,4'-piperidine]s
JP2002201177A (ja) 三環式縮合複素環誘導体、その製造法および用途

Legal Events

Date Code Title Description
RH Patent void